Reddit at Goldman Sachs Communacopia + Technology Conference 2026: growth push

With AI having become the frontline of an intense global competition for economic and geopolitical power, speed is rewarded, scale is celebrated, and market dominance is prized above all else. Under such conditions, we risk forgetting the most important question: Whom is this intelligence ultimately meant to serve? NEW DELHI—The defining question of our time…

RBA Governor Michele Bullock speaks at 1:05 pm Sydney time today and that’s the lone highlight on the Asia-Pacific calendar. It’s a quiet one but there are no local holidays, just a gap on the calendar. China will be in focus as we eye the second day of trading in CXMT, which deputed post-IPO with…

It’s rare for cyclosporiasis to cause death. These are the first deaths associated with the largest-ever cyclospora outbreak in the U.S.

EUR/GBP is holding a narrow band around the mid-0.8500s with little conviction in either direction. At the time of writing, the cross is close to flat on the day. The European Central Bank (ECB) raised rates in June, and markets continue to lean toward a further move at the September meeting, with persistent energy-driven inflation…

India’s economy is expanding rapidly, and prospects are good. But external factors like the Iran conflict could slow it down. This article appears in the July/August issue of Global Finance Magazine. Few large economies match India’s growth potential, which is supported by robust domestic demand, a strong banking sector, and sound macroeconomic fundamentals. But spillovers from…

Eli Lilly (LLY -1.06%) and Novo Nordisk (NVO -8.71%) are far and away the heavyweights in the global market for GLP-1 drugs, which effectively treat both type 2 diabetes and obesity. And that market is exploding, particularly for obesity drugs. The global market for obesity medicines reached $66 billion in 2025. Bloomberg predicts it will…